Sophie Pryor
Sophie Pryor is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. She is currently studying for a PhD in Developmental and Stem Cell Biology at University College London's Institute of Child Health, under the auspices of a Wellcome Trust supported programme. Her research is conducted in the laboratory of the Institute's Director Professor Andrew Copp, and focuses on the genetics and developmental basis of neural tube defects. Previously she studied Biology at the University of York, and went on to work as a DNA Analyst for the Forensic Science Service.
BioNews Comment articles written by Sophie Pryor:
|
Freeing us from our cells: avoiding inherited mitochondrial disease |
| 08 October 2012 - by |
|
On 25 September 2012 the Progress Educational Trust held a debate on the issues surrounding new techniques to prevent the transmission of mitochondrial disease. The event was organised in partnership with City University London's science journalism course and was supported by the Wellcome Trust.... [Read More] |
 |
BioNews News articles written by Sophie Pryor:
1/3 
|
HFEA launches public consultation on mitochondrial replacement techniques |
| 17 September 2012 - by |
|
The UK's Human Fertilisation and Embryology Authority (HFEA) has launched a public consultation on the social and ethical impact of new methods that could prevent the transmission of some incurable mitochondrial diseases.... [Read More] |
| |
| 20 August 2012 - by |
|
Families with higher levels of a protein linked to inflammation may be at a reduced risk of dementia.... [Read More] |
| |
|
Amniotic fluid could provide alternative to embryonic stem cells |
| 09 July 2012 - by |
|
Stem cells taken from amniotic fluid can be reprogrammed into a more versatile state similar to embryonic stem cells (ES cells) without the introduction of extra genes, UK scientists have found. The discovery offers hope that these cells could be banked for therapeutic use, research and drug screening... [Read More] |
| |
|
Florida doctor suspended following death of patient after unlicensed stem cell treatment |
| 19 March 2012 - by |
|
A cardiologist in Bonita Springs, Florida, USA, has had his medical licence suspended after allegedly performing an illegal stem cell treatment on a patient who died during the procedure... [Read More] |
| |
| 31 January 2012 - by |
|
The development of world's first artificial testicle for production of human sperm has been given the go ahead... [Read More] |
| |
| 28 November 2011 - by |
|
Mouse fetal stem cells can travel from the placenta to heal their mother's damaged heart, US scientists have found. The discovery may explain why some women who suffer heart failure during or shortly after pregnancy recover faster, and offers hope for new treatment methods using human fetal stem cells... [Read More] |
| |
| 18 July 2011 - by |
|
Doctors in the USA have begun treating patients in two clinical trials for degenerative eye diseases. The studies at the Jules Stein Eye Institute at the University of California, Los Angeles (UCLA), will test whether specialised eye cells, which have been produced from human embryonic stem cells (hESCs), can be used to treat dry age-related macular degeneration (dry AMD) and Stargardt's macular dystrophy.... [Read More] |
| |
|
Stem cells used to successfully treat damaged heart muscle in mice |
| 13 June 2011 - by |
|
A naturally occurring protein can activate stem cells in mouse hearts, producing new muscle cells to replace the tissue damaged by a heart attack, UK scientists have found... [Read More] |
| |
|
Canadian study suggests that single-embryo transfer is safer option |
| 18 April 2011 - by |
|
The authors of a new Canadian study have recommended a mandatory policy of single embryo transfer in an aim to reduce health complications arising from multiple births.... [Read More] |
| |
| 28 March 2011 - by |
|
US scientists have taken an important step towards using stem cells to treat age-related macular degeneration (AMD), the leading cause of blindness in the UK. The study demonstrates, for the first time, the ability to direct human iPS (induced pluripotent stem) cells to become... [Read More] |
| |
1/3
| Progress Educational Trust, 140 Grays Inn Road, London WC1X 8AX, UK Tel: +44 (0)20 7278 7870 Email: Limited company registered in England and Wales no 07405980 Charity registered in England and Wales no 1139856 |
Website developed and built by Face to Face |
© 1999, 2013
BioNews